Pratidin
Science and technology19 November 2026PIB, Government releaseGS3GS2

India's first indigenous H5N1 bird flu vaccine for chickens to be dedicated on 20 November

In one line: ICAR-NIHSAD, Bhopal has developed India's first indigenous inactivated vaccine for chickens against the H5N1 bird flu strain (clade 2.3.2.1a) that causes most Indian outbreaks.

Published 19 November 2026. Written by Pratidin from the reports linked at the end; every fact checked by a separate review before publishing. How we work

The Ministry of Agriculture and Farmers Welfare said that Union Agriculture Minister Shivraj Singh Chouhan will dedicate to the nation, on 20 November 2026, India's first indigenous inactivated vaccine for chickens against H5N1 highly pathogenic avian influenza (HPAI) of clade 2.3.2.1a. The vaccine was developed by the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal, where the event will be held. The ministry says clade 2.3.2.1a has caused most bird flu outbreaks in chickens in India, and that no specific commercial vaccine is currently available against it.

The release sets out the cost of the disease. Since India first detected H5N1 in 2006, more than 500 combined outbreaks of the H5N1 and H5N8 subtypes have been reported. Outbreaks can cause nearly 100% mortality among infected birds, and culling and trade restrictions add to farmers' losses. The 2006 outbreak caused estimated losses of ₹2,200 to 3,000 crore, and an outbreak in Manipur cost about 0.5% of the State's GDP. The ministry estimates that a major outbreak could reduce India's GDP growth by up to 1.5%, and that more than 20% of the poultry population could be at risk if the disease spreads unchecked.

There is a human health side too. The release cites WHO data of 1,003 human H5N1 cases, including 479 deaths, in 25 countries, India among them, since 2003, and says clade 2.3.2.1a has been detected in various mammals and in three human cases. H5N1 was first identified in farmed birds in southern China in 1996; human-to-human transmission has been rare. Protecting poultry thus also lowers human risk, the idea behind the One Health approach. The release does not say how the vaccine will be deployed alongside existing control measures or when it will be commercially available.

Practise this in the app: flashcards, quiz and a timed answer
Prelims

Prelims facts

  • ICAR-NIHSAD, Bhopal has developed India's first indigenous inactivated H5N1 (clade 2.3.2.1a) HPAI vaccine for chickens, to be dedicated on 20 November 2026.
  • Clade 2.3.2.1a has caused most bird flu outbreaks in Indian chickens; no specific commercial vaccine existed for it.
  • India has reported more than 500 H5N1 and H5N8 outbreaks since its first detection in 2006.
  • WHO records 1,003 human H5N1 cases and 479 deaths in 25 countries since 2003.
  • In H5N1, H stands for haemagglutinin and N for neuraminidase, two surface proteins of the virus.

Quick recall

Which institute developed India's first indigenous H5N1 chicken vaccine?
ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal.
Which H5N1 clade does the vaccine target?
Clade 2.3.2.1a, behind most chicken outbreaks in India.
What type of vaccine is it?
Inactivated, made from killed virus.
When was H5N1 first detected in India?
2006.
H5N1 and H5N8 outbreaks reported in India since 2006?
More than 500.
Human H5N1 cases and deaths reported to WHO since 2003?
1,003 cases and 479 deaths in 25 countries.
What do H and N stand for in H5N1?
Haemagglutinin and neuraminidase, two surface proteins.
Where and when was H5N1 first identified?
In farmed birds in southern China, 1996.

Prelims practice question

With reference to the vaccine for chickens announced by the Ministry of Agriculture and Farmers Welfare in November 2026, consider the following statements:
1. It is a live attenuated vaccine.
2. It targets H5N1 viruses of clade 2.3.2.1a.
3. It was developed by an institute of the Indian Council of Agricultural Research.
Which of the statements given above are correct?

  1. 1 and 2 only
  2. 2 and 3 only
  3. 1 and 3 only
  4. 1, 2 and 3
Show answer

Answer: (b) 2 and 3 only. Statement 1 is wrong: it is an inactivated (killed-virus) vaccine. Statements 2 and 3 are correct: it targets clade 2.3.2.1a and was developed by ICAR-NIHSAD, Bhopal.

Use this in UPSC Mains: previous-year questions

Recurring theme: Biotechnology for farm livelihoods and animal health: vaccines, zoonoses and One Health

  1. 2019 · GS3 · 15 marksAnswers it directlyUse it in the example

    How can biotechnology help to improve the living standards of farmers?

    How to use this

    Use the indigenous bird flu vaccine as a concrete example of biotechnology shielding farmers from disease-driven income shocks.

    • ICAR-NIHSAD, Bhopal developed India's first indigenous inactivated H5N1 (clade 2.3.2.1a) chicken vaccine, to be dedicated on 20 November 2026.
    • India has had 500+ H5N1 and H5N8 outbreaks since 2006, with nearly 100% mortality in infected birds and losses from culling.
    • The 2006 outbreak cost ₹2,200 to 3,000 crore; a major outbreak could cut GDP growth by up to 1.5%.
  2. 2015 · GS3 · 12.5 marksCovers one partUse it in the body

    Livestock rearing has a big potential for providing non-farm employment and income in rural areas. Discuss suggesting suitable measures to promote this sector in India.

    How to use this

    Argue that animal disease control, through measures like the new bird flu vaccine, is essential to realise the income potential of livestock rearing.

    • Bird flu can kill nearly all infected birds and put over 20% of India's poultry at risk if unchecked.
    • An indigenous vaccine against clade 2.3.2.1a, which causes most chicken outbreaks in India, reduces this risk for poultry farmers.
Also asked on this theme
  1. 2020 · GS2 · 10 marks

    Critically examine the role of WHO in providing global health security during the COVID-19 Pandemic.

Mains practice question

How can biotechnology protect the livelihoods of livestock farmers? Discuss with reference to India's indigenous bird flu vaccine for chickens. (250 words)

Model answer

Poultry is a major source of rural income, and bird flu outbreaks can wipe out flocks. The indigenous inactivated H5N1 (clade 2.3.2.1a) chicken vaccine developed by ICAR-NIHSAD, Bhopal, to be dedicated on 20 November 2026, shows how biotechnology can protect farmers' livelihoods.

How biotechnology helps farmers

  • Disease protection: vaccines matched to local strains; India has had 500+ H5N1 and H5N8 outbreaks since 2006, with nearly 100% mortality in infected birds.
  • Income security: fewer culls and trade curbs; the 2006 outbreak cost ₹2,200 to 3,000 crore and one in Manipur cost 0.5% of the State's GDP.
  • Indigenous capability: no specific commercial vaccine existed for clade 2.3.2.1a; local development cuts import dependence.
  • Macro stability: the ministry estimates a major outbreak could cut GDP growth by up to 1.5%.
  • Public health: WHO records 1,003 human H5N1 cases and 479 deaths since 2003; reducing infection in birds lowers human risk (One Health).

Challenges

  • Strategy for use alongside culling and surveillance is not yet public.
  • Cold chain and reach to small backyard farmers.
  • Viruses evolve; vaccines need regular updating.

Way forward

  • Clear national vaccination protocol with continued surveillance.
  • Affordable supply through cooperatives and veterinary services.
  • Link with One Health data sharing between animal and human health agencies.

Strain-specific, locally made animal vaccines can turn a recurring income shock for poultry farmers into a manageable risk.

The basics

Why this matters

Bird flu can wipe out a poultry farm in days and, rarely, infect people. India has relied on detecting outbreaks and culling birds. On 18 November 2026 the Agriculture Ministry announced that Union Minister Shivraj Singh Chouhan would dedicate to the nation, on 20 November at ICAR-NIHSAD in Bhopal, India's first indigenous inactivated vaccine for chickens against H5N1 Highly pathogenic avian influenza of clade 2.3.2.1a, the strain behind most outbreaks in Indian chickens.

500+
combined H5N1 and H5N8 outbreaks reported in India since the first detection in 2006
Outbreaks can kill nearly 100% of infected birds, and culling and trade curbs add to farmers' losses.

Reading the virus's name

What 'H5N1 clade 2.3.2.1a' means
  1. 1H5The fifth known type of haemagglutinin, a surface protein the virus uses to enter cells
  2. 2N1The first type of neuraminidase, a surface protein that helps new virus particles leave the cell
  3. 3Highly pathogenicCauses severe disease and sudden death in chickens
  4. 4Clade 2.3.2.1aA genetic lineage of H5N1; the one behind most chicken outbreaks in India

The cost of outbreaks

H5N1 and India
  1. 1996H5N1 first identified in farmed birds in southern China
  2. 1997First known human infections, in Hong Kong
  3. 2006First detection in India; losses estimated at ₹2,200 to 3,000 crore
  4. 18 November 2026Agriculture Ministry announces the indigenous clade 2.3.2.1a vaccine
  5. 20 November 2026Vaccine to be dedicated to the nation at ICAR-NIHSAD, Bhopal

Why a vaccine, and why now

According to the ministry, no commercial vaccine is currently available specifically against clade 2.3.2.1a. The new product is an Inactivated vaccine, made from killed virus. Protecting birds also protects people: clade 2.3.2.1a has been found in other animals and in three human cases. That is the logic of One Health, which treats human, animal and environmental health as linked. The developer, ICAR-NIHSAD, is the Indian Council of Agricultural Research's institute for high-security animal diseases.

Go deeper

Why it matters for UPSC

The story combines GS3 science (vaccines, indigenous technology), agriculture and livestock (poultry incomes), and GS2 health (zoonoses, One Health). Prelims often tests virus naming, vaccine types and institutions.

The core idea

Highly pathogenic avian influenza spreads fast among poultry and can kill almost every infected bird. India has seen more than 500 H5N1 and H5N8 outbreaks since 2006. An Inactivated vaccine matched to the local clade could cut losses. Because the virus can jump to mammals and humans, the step fits the One Health approach. The vaccine was developed by ICAR-NIHSAD.

Numbers and dates to remember

  • 20 November 2026: dedication at ICAR-NIHSAD, Bhopal
  • 2006: first detection in India; losses ₹2,200 to 3,000 crore
  • 500+: H5N1 and H5N8 outbreaks since 2006
  • Up to 1.5%: possible cut in GDP growth from a major outbreak (ministry estimate)
  • 1,003 human H5N1 cases and 479 deaths in 25 countries since 2003 (WHO, cited by the ministry)
  • 3: human cases of clade 2.3.2.1a infection

Where to go next

Go deeper: vaccinate, or keep culling?

The case for the vaccine. The ministry's figures show why bird flu is costly: nearly 100% mortality among infected birds, more than 20% of the poultry population at risk if spread is uncontrolled, losses of ₹2,200 to 3,000 crore in 2006, and an outbreak in Manipur that cost 0.5% of the State's GDP. A vaccine matched to the clade circulating in India, clade 2.3.2.1a of Highly pathogenic avian influenza, could protect flocks and farm incomes, and it is indigenous, developed by ICAR-NIHSAD.

The public health angle. WHO figures cited by the ministry record 1,003 human H5N1 cases and 479 deaths in 25 countries since 2003, including India. Human-to-human spread has been rare, but every infection in birds and mammals gives the virus a chance to change. Reducing infection in poultry is therefore a One Health measure.

The questions. The release does not say how the vaccine will be used: whether across flocks, around outbreak zones, or alongside continued culling, or when it will be commercially available. Vaccinated birds can sometimes carry infection with fewer signs, so surveillance must continue. These details will decide how much difference the Inactivated vaccine makes.

Highly pathogenic avian influenza

What bird flu is and how its strains are named

In one line: Highly pathogenic avian influenza (HPAI) is a severe form of bird flu, caused by influenza A viruses such as H5N1, that can kill most infected poultry.

How flu viruses are named

Influenza A viruses are named after two surface proteins. H stands for haemagglutinin and N for neuraminidase; H5 is the fifth known type of haemagglutinin and N1 the first type of neuraminidase. Within H5N1, scientists group related viruses into clades, or genetic lineages, such as 2.3.2.1a, common in Indian chickens, and 2.3.4.4b, which has spread widely among birds and mammals since 2020.

History

H5N1 was first identified in farmed birds in southern China in 1996. The first known human infections were in Hong Kong in 1997. India first detected it in 2006. In chickens, HPAI causes breathing problems, a sharp fall in egg production and sudden death.

Where to go next

Inactivated vaccine

How a killed-virus vaccine trains the immune system

In one line: An inactivated vaccine contains a virus that has been killed, so it cannot multiply, but it still carries the proteins that teach the immune system to recognise the real virus.

How it works

The virus is grown and then inactivated. When injected, its surface proteins, such as haemagglutinin in flu, prompt the body to make antibodies. If the animal later meets the live virus, the immune system responds quickly. Because the virus cannot replicate, such vaccines are considered safe, but they may need booster doses.

Why matching the strain matters

Flu viruses change, so a vaccine works best when it matches the circulating lineage. The new Indian vaccine is made against H5N1 clade 2.3.2.1a, the clade behind most Indian chicken outbreaks, for which the ministry says no specific commercial vaccine is available.

Where to go next

One Health

Why animal health is also a human health issue

In one line: One Health is the approach that treats the health of people, animals and the environment as linked, so that diseases are tackled across all three together.

Why it applies here

Avian influenza is a zoonosis, a disease that can pass from animals to humans. WHO has recorded 1,003 human H5N1 cases and 479 deaths in 25 countries since 2003, including India. Clade 2.3.2.1a has been detected in various mammals and in three human cases. Controlling infection in poultry lowers the chance of human exposure and of the virus adapting to new hosts.

In practice

One Health needs veterinary and human health services to share surveillance data, coordinate responses to outbreaks and invest in prevention such as animal vaccination and biosecurity on farms.

Where to go next

One Health: every story that connects to it (3)

ICAR-NIHSAD

The Bhopal institute that developed the vaccine

In one line: ICAR-NIHSAD is the National Institute of High Security Animal Diseases in Bhopal, an institute of the Indian Council of Agricultural Research (ICAR).

What it does

As its name says, the institute works on high-security animal diseases, those dangerous enough to need special containment, such as highly pathogenic avian influenza. ICAR itself works under the Union Ministry of Agriculture and Farmers Welfare.

Why it is in the news

ICAR-NIHSAD developed the inactivated H5N1 (clade 2.3.2.1a) vaccine for chickens. The Union Agriculture Minister is to dedicate it to the nation at the institute on 20 November 2026.

Where to go next

Syllabus

Related stories

Sources used for this summary